With great support from UIC - Uppsala Innovation Centre we had the oportunity to present Cellda at Gothenburg’s and west Sweden’s annual venture capital forum for investors, startups and scaleups, 7-8 February. There were great lectures and good networking which we are sure will contribute in the development of Cellda.
Cellda AB
Tillverkning av medicintekniska produkter
Safe, fast and objective computerized cancer diagnostics.
Om oss
We are engaged in the fight against cancer. At Cellda (formerly MM18 Medical) we focus on digital pathology and computer assisted analysis of tissue sections of human cancer, initially prostate cancer. Globally prostatic adenocarcinoma is the second most frequent malignancy after lung cancer in men, about 1,300,000 cases and causing about 360,000 deaths per year. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide. Our aim is to obtain reproducible, correct and objective histo-pathological diagnoses replacing microscopic examinations. Our product CelldaTM offers clearer indication of pre cancer stages. It also reduces intra- and interobserver variability in lab results to better serve the remitting urologist. The method also reduces overall costs and avoids under- and over-diagnosis.
- Webbplats
-
http://www.cellda.com
Extern länk för Cellda AB
- Bransch
- Tillverkning av medicintekniska produkter
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Uppsala
- Typ
- Privatägt företag
- Grundat
- 2018
- Specialistområden
- MedTech , Prostate cancer, Computer assisted diagnostics, AI, Digital pathology, Biopsy, Image analysis, Diagnostic, Software, Adenocarcinoma, LGPIN, HGPIN, Antibody, Microscopy, Scanning, Medical tissue, Automatic, Research och Medical device
Adresser
-
Primär
Få vägbeskrivning
Uppsala, SE
Anställda på Cellda AB
Uppdateringar
-
This week, our CEO Susanne Bredenberg had a great time at the 10th Digital Pathology & AI Congress Europe, in London with networking and learnings on recent advancings and innovations in Digital Pathologi and AI as well as interesting discussions when presenting our poster - Prevalence of premalignant lesions in triple immuno-stained prostate biopsies.
-
-
Great event by #UIC: Pitch and mingle with board professionals from #Styrelseakademin, also supported by #Brann. Thank you for the opportunity to present Cellda and listening to great talks by the other Accelerator companies #Dripp, #VivoLogica, #SustainableAdvantage and #PipersHive
-
-
Join us tomorrow at Uppsala Innovation Day! We're excited to make new connections, gain fresh insights, and get inspired. See you there! #UppsalaInnovationDay
-